U.S. Rep. Katie Porter (D-Calif.), a California Democrat with a significant national profile, yesterday introduced legislation to require drug manufacturers to pay a Medicare Part B rebate for certain drugs if the price of such drugs increases faster than inflation.
Porter’s Freedom from Price Gouging Act (H.R. 2706) would apply to single-source drugs and biologicals that cost $100 or more and are paid for under Medicare fee for service. The bill raises the possibility of extending the rebate to multiple-source drugs and drugs paid for under Medicare Advantage plans, after the U.S. Health and Human Services Department (HHS) conducts a feasibility study.
U.S. Rep. Katie Porter (D-Calif.), a California Democrat with a significant national profile, yesterday introduced legislation to require drug manufacturers to pay a Medicare Part B rebate for certain drugs if the price of such drugs increases faster than inflation.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
